Montelukast vs Upadacitinib

## Montelukast vs Upadacitinib: Overview

This comparison examines the pharmacological differences between **Montelukast** and **Upadacitinib**.

## Mechanism of Action

**Montelukast**: Selective leukotriene D4 receptor antagonist.

**Upadacitinib**: Selective JAK1 inhibitor reducing signaling from cytokines implicated in autoimmune diseases.

## Pharmacokinetics

**Half-life**: Montelukast — 2.7-5.5 hours; Upadacitinib — 9-14 hours.

## Chemical Properties

**Molecular Formula**: Montelukast — C35H36ClNO3S; Upadacitinib — C17H19F3N6O.

**Molecular Weight**: Montelukast — 586.1800 g/mol; Upadacitinib — 380.3700 g/mol.

**Type**: Montelukast — Small molecule; Upadacitinib — Small molecule.